Tuberculosis Trials Consortium Services
Closed Solicitation Posted
This opportunity was awarded. See its 6 award notices in the notice history.
- Solicitation number
- 75D30120R67869
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- USA
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals to provide clinical trial and research support services for tuberculosis treatment, diagnosis, and prevention studies over a ten-year period from 2020 through 2030. The Centers for Disease Control and Prevention will evaluate proposals based on technical approach, staff qualifications, experience conducting similar clinical research, quality assurance capabilities, and past performance. Services include conducting all phases of domestic and international clinical trials for both latent and active tuberculosis, recruiting and enrolling participants, collecting and reporting data, and participating in consortium committees and meetings. Proposals are due by June 16, 2020.
There is no set-aside designation. Relevant NAICS codes include 541715 and PSC code R425. The estimated total contract value is $50 million over ten years to support an estimated 0-4 new studies annually. Domestic sites must enroll minimum numbers of latent and active tuberculosis patients yearly. Performance will occur within the United States under an indefinite delivery/indefinite quantity contract with a one-year base period and nine one-year options.
Notice text
5 versions
Update #5 · Latest ·
Amendment 00004 is hereby issued to post revisions to Section J of the solicitation document. Please review Amendment 00004 in it's entirety.
Amendment 00003 is hereby issued to post revisions to section L of the solicitation document. Please review amendment 00003 in it's entirety.
Amendment 00002 is hereby issued to post revisions to the PWS and Section M of the solicitation document. Please review amendment 00002 in it's entirety.
Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.
Update #4 ·
Amendment 00003 is hereby issued to post revisions to section L of the solicitation document. Please review amendment 00003 in it's entirety.
Amendment 00002 is hereby issued to post revisions to the PWS and Section M of the solicitation document. Please review amendment 00002 in it's entirety.
Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.
Update #3 ·
Amendment 00002 is hereby issued to post revisions to the PWS and Section M of the solicitation document. Please review amendment 00002 in it's entirety.
Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.
Update #2 ·
Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.
Update #1 ·
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.
Attachments
Show all 21
Notice history
| Notice | Type | Posted |
|---|---|---|
| Tuberculosis Trials Consortium Services | Award Notice | |
| Tuberculosis Trials Consortium Services | Award Notice | |
| Tuberculosis Trials Consortium Services | Award Notice | |
| Tuberculosis Trials Consortium Services | Solicitation | |
| Tuberculosis Trials Consortium Services | Pre-Solicitation |
And 3 more award notices.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity